<?xml version='1.0' encoding='utf-8'?>
<document id="19927376"><sentence text="Stereoselective protein binding of tetrahydropalmatine enantiomers in human plasma, HSA, and AGP, but not in rat plasma."><entity charOffset="35-54" id="DDI-PubMed.19927376.s1.e0" text="tetrahydropalmatine" /></sentence><sentence text="Tetrahydropalmatine (THP) is one of the active alkaloid ingredients of Rhizoma Corydalis"><entity charOffset="0-19" id="DDI-PubMed.19927376.s2.e0" text="Tetrahydropalmatine" /><entity charOffset="21-24" id="DDI-PubMed.19927376.s2.e1" text="THP" /><entity charOffset="47-55" id="DDI-PubMed.19927376.s2.e2" text="alkaloid" /><pair ddi="false" e1="DDI-PubMed.19927376.s2.e0" e2="DDI-PubMed.19927376.s2.e0" /><pair ddi="false" e1="DDI-PubMed.19927376.s2.e0" e2="DDI-PubMed.19927376.s2.e1" /><pair ddi="false" e1="DDI-PubMed.19927376.s2.e0" e2="DDI-PubMed.19927376.s2.e2" /><pair ddi="false" e1="DDI-PubMed.19927376.s2.e1" e2="DDI-PubMed.19927376.s2.e1" /><pair ddi="false" e1="DDI-PubMed.19927376.s2.e1" e2="DDI-PubMed.19927376.s2.e2" /></sentence><sentence text=" THP has a chiral center, and the stereoselective pharmacokinetics and tissue distribution have been reported"><entity charOffset="1-4" id="DDI-PubMed.19927376.s3.e0" text="THP" /></sentence><sentence text=" The aim of the present article is to study the stereoselective protein binding of THP using equilibrium dialysis followed by HPLC-UV analysis"><entity charOffset="83-85" id="DDI-PubMed.19927376.s4.e0" text="THP" /></sentence><sentence text=" The results showed that THP stereoselectively binds to human serum albumin (HSA), alpha(1)-acid glycoprotein (AGP), and proteins in human plasma"><entity charOffset="25-27" id="DDI-PubMed.19927376.s5.e0" text="THP" /></sentence><sentence text=" The fraction binding of (+)-THP was significantly higher than that of (-)-THP, whereas such stereoselectivity was not found in rat plasma"><entity charOffset="29-31" id="DDI-PubMed.19927376.s6.e0" text="THP" /><entity charOffset="75-77" id="DDI-PubMed.19927376.s6.e1" text="THP" /><pair ddi="false" e1="DDI-PubMed.19927376.s6.e0" e2="DDI-PubMed.19927376.s6.e0" /><pair ddi="false" e1="DDI-PubMed.19927376.s6.e0" e2="DDI-PubMed.19927376.s6.e1" /></sentence><sentence text=" The affinity of HSA and AGP to (+)-THP, expressed as nK(A), were 9"><entity charOffset="36-38" id="DDI-PubMed.19927376.s7.e0" text="THP" /></sentence><sentence text="0 x 10(3) M(-1) and 2" /><sentence text="34 x 10(5) M(-1), respectively, which were notablely higher than to (-)-THP, with the nK(A) of 3"><entity charOffset="72-74" id="DDI-PubMed.19927376.s9.e0" text="THP" /></sentence><sentence text="4 x 10(3) M(-1) and 1" /><sentence text="44 x 10(5) M(-1), respectively" /><sentence text=" The binding site of HSA for (-)-THP was Site I, whereas for (+)-THP was both Site I and Site II"><entity charOffset="33-35" id="DDI-PubMed.19927376.s12.e0" text="THP" /><entity charOffset="65-67" id="DDI-PubMed.19927376.s12.e1" text="THP" /><pair ddi="false" e1="DDI-PubMed.19927376.s12.e0" e2="DDI-PubMed.19927376.s12.e0" /><pair ddi="false" e1="DDI-PubMed.19927376.s12.e0" e2="DDI-PubMed.19927376.s12.e1" /></sentence><sentence text=" The F1/S variants of AGP were proved to be the key variants (-)- and (+)-THP binding to both"><entity charOffset="74-76" id="DDI-PubMed.19927376.s13.e0" text="THP" /></sentence><sentence text=" Finally, the AGP binding drugs, such as mifepristone, were demonstrated to reduce the fraction binding of (-)- and (+)-THP with pure AGP (1 mg/ml) but did not affect the fraction binding of both (-)- and (+)-THP with proteins in human plasma"><entity charOffset="41-53" id="DDI-PubMed.19927376.s14.e0" text="mifepristone" /><entity charOffset="120-131" id="DDI-PubMed.19927376.s14.e1" text="THP" /><entity charOffset="209-220" id="DDI-PubMed.19927376.s14.e2" text="THP" /><pair ddi="false" e1="DDI-PubMed.19927376.s14.e0" e2="DDI-PubMed.19927376.s14.e0" /><pair ddi="false" e1="DDI-PubMed.19927376.s14.e0" e2="DDI-PubMed.19927376.s14.e1" /><pair ddi="false" e1="DDI-PubMed.19927376.s14.e0" e2="DDI-PubMed.19927376.s14.e2" /><pair ddi="false" e1="DDI-PubMed.19927376.s14.e1" e2="DDI-PubMed.19927376.s14.e1" /><pair ddi="false" e1="DDI-PubMed.19927376.s14.e1" e2="DDI-PubMed.19927376.s14.e2" /></sentence><sentence text=" It can be concluded that protein binding of THP is species dependent and stereoselective, both HSA and AGP contribute to the stereoselective binding to THP enatiomers, and AGP binding drugs may not cause the drug-drug interaction on THP in healthy human plasma"><entity charOffset="45-47" id="DDI-PubMed.19927376.s15.e0" text="THP" /><entity charOffset="153-155" id="DDI-PubMed.19927376.s15.e1" text="THP" /><entity charOffset="234-236" id="DDI-PubMed.19927376.s15.e2" text="THP" /><pair ddi="false" e1="DDI-PubMed.19927376.s15.e0" e2="DDI-PubMed.19927376.s15.e0" /><pair ddi="false" e1="DDI-PubMed.19927376.s15.e0" e2="DDI-PubMed.19927376.s15.e1" /><pair ddi="false" e1="DDI-PubMed.19927376.s15.e0" e2="DDI-PubMed.19927376.s15.e2" /><pair ddi="false" e1="DDI-PubMed.19927376.s15.e1" e2="DDI-PubMed.19927376.s15.e1" /><pair ddi="false" e1="DDI-PubMed.19927376.s15.e1" e2="DDI-PubMed.19927376.s15.e2" /></sentence><sentence text="" /></document>